These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3135291)

  • 41. Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.
    Steis RG; Urba WJ; VanderMolen LA; Bookman MA; Smith JW; Clark JW; Miller RL; Crum ED; Beckner SK; McKnight JE
    J Clin Oncol; 1990 Oct; 8(10):1618-29. PubMed ID: 2213099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T; Sone S; Tandon P; Ogawara M; Shimizu E; Nii A; Nakanishi M; Shono M; Ogura T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3161-8. PubMed ID: 3096216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon.
    Böhle A; Thanhäuser A; Ulmer AJ; Ernst M; Flad HD; Jocham D
    J Urol; 1993 Dec; 150(6):1932-7. PubMed ID: 8230540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.
    Parihar R; Nadella P; Lewis A; Jensen R; De Hoff C; Dierksheide JE; VanBuskirk AM; Magro CM; Young DC; Shapiro CL; Carson WE
    Clin Cancer Res; 2004 Aug; 10(15):5027-37. PubMed ID: 15297404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
    Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
    Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations.
    Urba WJ; Clark JW; Steis RG; Bookman MA; Smith JW; Beckner S; Maluish AE; Rossio JL; Rager H; Ortaldo JR
    J Natl Cancer Inst; 1989 Apr; 81(8):602-11. PubMed ID: 2495368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon gamma encapsulated into liposomes enhances the activity of monocytes and natural killer cells and has antiproliferative effects on tumor cells in vitro.
    Rutenfranz I; Bauer A; Kirchner H
    Blut; 1990 Jul; 61(1):30-7. PubMed ID: 2117474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
    Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
    Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
    Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G
    J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.
    Vankayalapati R; Klucar P; Wizel B; Weis SE; Samten B; Safi H; Shams H; Barnes PF
    J Immunol; 2004 Jan; 172(1):130-7. PubMed ID: 14688318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferon.
    Stevenson GW; Hall S; Rudnick SJ; Alvord G; Rossio J; Urba W; Leventhal JB; Miller P; Seleny F; Stevenson HC
    Immunopharmacol Immunotoxicol; 1987; 9(4):489-510. PubMed ID: 3125239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential modulation of cord blood and peripheral blood monocytes by intravenous immunoglobulin.
    Gille C; Dreschers S; Spring B; Tárnok A; Bocsi J; Poets CF; Orlikowsky TW
    Cytometry B Clin Cytom; 2012 Jan; 82(1):26-34. PubMed ID: 21812105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
    Pestieau SR; Sugarbaker PH
    Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.
    Weiner LM; Steplewski Z; Koprowski H; Litwin S; Comis RL
    Cancer Res; 1988 Feb; 48(4):1042-6. PubMed ID: 3123051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.
    Fisher RI; Coltman CA; Doroshow JH; Rayner AA; Hawkins MJ; Mier JW; Wiernik P; McMannis JD; Weiss GR; Margolin KA
    Ann Intern Med; 1988 Apr; 108(4):518-23. PubMed ID: 3258138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Meerpohl HG; Leser HG; Engler H; Löhr GW
    Cancer Res; 1990 Dec; 50(23):7450-6. PubMed ID: 1701343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes.
    Nagai T; Yanagida T; Hirohata S
    Mod Rheumatol; 2011 Feb; 21(1):57-62. PubMed ID: 20824297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.